Qiming-backed Gan & Lee hits ceiling to reach $5.2B market cap in first day on Shanghai

The latest in a string of Qiming portfolio companies to go public, Gan & Lee saw its stock gain the maximum allowed by the Shanghai exchange in its first day of trading to bring its market cap to more than $5 billion.

Shares of Gan & Lee Pharmaceuticals (Shanghai:603087) rose RMB27.86 (44%) to RMB91.18 two weeks after raising

Read the full 577 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE